🟢 Rezolute is trading 13.72% up in pre-market with no clear catalyst identified

Rezolute is trading at $4.56, up +13.72% in pre-market, with no clear catalyst established.

• No fresh company announcement explaining the October 5 pre-market move was identified.
• The latest company news found was its September 24 fiscal 2026 results and business update.
• Phase 3 sunRIZE data remains under FDA review after missing the primary endpoint. Major indices were modestly lower in the supplied pre-market context, so broad-market strength does not explain the gain.